FIELD: molecular biology, microbiological industry, medicinal biotechnology, genetic engineering. SUBSTANCE: invention proposes recombinant plasmid DNA pSA V27 encoding synthesis of soluble streptavidine secreted into periplasm and used as the base for construction of the strain Escherichia coli VKPM B-7758 as a producer of streptavidine. Strain accumulates 180-240 mg/l of streptavidine in cultural fluid for 1-14 h of fermentation. EFFECT: recombinant plasmid indicated above, increased yield of streptavidine. 3 cl, 3 dwg, 4 ex
Authors
Dates
2000-07-27—Published
1999-05-14—Filed